Randall W Armstrong, MD
Family Practice · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 43 years
- University of California, Geffen School of Medicine, 1983
Offices
1 location
Looking this up.
Hospitals listed: Sutter Amador Hospital · Sutter Medical Center, Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Armstrong’s office at (916) 732-3348 to ask if they take your plan before you enroll.
California Medical Board record
Licence G53496 · Current
Licensed to practise in California · since 1984 · expires 2027-12-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Amador HospitalJackson, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Amador Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 180 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.6 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.3) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.81 (0 to 1.84) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 138 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.8 · 230 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 226 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.9) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.6) · 146 cases | No different | Jan 2022 – Dec 2024 |
What patients said (385 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$133,225
Medicare paid this office $133,225 for 333 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 187 | $27,192 | $101 |
| Short return visit (20+ min) | 203 | $25,255 | $66 |
| Return visit (30+ min) | 176 | $24,874 | $95 |
| New patient visit (45+ min) | 97 | $11,850 | $122 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 167 | $11,055 | $46 |
See all 13 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 187 | $27,192 | $101 |
| Short return visit (20+ min) | 203 | $25,255 | $66 |
| Return visit (30+ min) | 176 | $24,874 | $95 |
| New patient visit (45+ min) | 97 | $11,850 | $122 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 167 | $11,055 | $46 |
| Short return visit | 169 | $10,115 | $43 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 112 | $8,418 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 82 | $4,968 | $50 |
| New patient visit (60+ min) | 22 | $3,322 | $151 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 28 | $2,416 | $76 |
| Long return visit (40+ min) | 14 | $1,726 | $123 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | $1,012 | $63 |
| Injection, methylprednisolone acetate, 1 mg | 22 | $105 | None |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 1-10 | None |
| Spinal fusion | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 309 | 245 | 283 | 280 | 270 | 268 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 296 | 238 | 277 | 273 | 256 | 238 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 147 | 128 | 142 | 141 | 126 | 143 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 96 | 79 | 94 | 99 | 77 | 99 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | 17 | 23 | 20 | 27 | 32 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | 12 | 12 | 16 | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
333 Original Medicare patients in 2024. Average age 77 · Women 54% · Also on Medicaid 5% · Health risk score 1.01. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 69% · Diabetes 26% · Coronary heart disease 26% · Chronic kidney disease 21% · Atrial fibrillation 20% · Depression 17% · Cancer 16% · Heart failure 13% · COPD 13% · Dementia 5% · Stroke 5%.
The office billed $471,411, Medicare allowed $175,619 and paid $133,225; for 2,858 services of 19 kinds; $174 of it was for drugs given in the office and $133,051 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 333 | 2,858 | 77 | 1.01 | $471,411 | $133,225 |
| 2023 | 327 | 1,827 | 76 | 1.09 | $444,745 | $137,404 |
| 2022 | 352 | 2,044 | 76 | 0.95 | $479,290 | $142,532 |
| 2021 | 406 | 2,503 | 76 | 0.94 | $572,831 | $185,666 |
| 2020 | 356 | 2,091 | 75 | 1.02 | $491,757 | $130,866 |
| 2019 | 462 | 2,560 | 76 | 1.10 | $637,186 | $173,095 |
| 2018 | 480 | 3,054 | 75 | 1.01 | $826,627 | $204,448 |
| 2017 | 497 | 3,186 | 74 | 1.02 | $1,031,760 | $235,643 |
| 2016 | 505 | 2,977 | 75 | 1.04 | $1,159,830 | $253,607 |
| 2015 | 536 | 2,971 | 75 | 1.08 | $1,229,405 | $267,189 |
| 2014 | 532 | 2,888 | 74 | 1.04 | $1,281,475 | $272,828 |
| 2013 | 509 | 2,428 | 74 | 1.04 | $956,362 | $232,978 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 189 | $30,135 | $112 |
| Return visit (30+ min) | 159 | $25,528 | $103 |
| Short return visit (20+ min) | 163 | $18,399 | $73 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 169 | $13,110 | $51 |
| Short return visit | 171 | $10,197 | $46 |
| New patient visit (45+ min) | 59 | $7,776 | $132 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 103 | $7,543 | $60 |
| New patient visit (60+ min) | 44 | $7,354 | $167 |
| Long return visit (40+ min) | 48 | $7,064 | $147 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 68 | $4,249 | $55 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 24 | $2,269 | $84 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 122 | $1,413 | $10 |
| Injection, methylprednisolone acetate, 80 mg | 26 | $268 | None |
2022: 15 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 202 | $31,435 | $112 |
| Return visit (30+ min) | 143 | $20,098 | $102 |
| Short return visit (20+ min) | 169 | $16,665 | $72 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 178 | $14,028 | $51 |
| Short return visit | 188 | $11,539 | $46 |
| Long return visit (40+ min) | 67 | $9,943 | $142 |
| New patient visit (45+ min) | 76 | $9,929 | $131 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 115 | $8,398 | $60 |
| New patient visit (60+ min) | 43 | $7,343 | $171 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 83 | $5,411 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 214 | $3,024 | $10 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 18 | $1,600 | $80 |
| New patient visit (30+ min) | 18 | $1,399 | $78 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,124 | $70 |
| Injection, methylprednisolone acetate, 80 mg | 18 | $164 | None |
2021: 16 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 211 | $34,082 | $120 |
| Return visit (30+ min) | 185 | $28,545 | $109 |
| Short return visit (20+ min) | 179 | $20,607 | $77 |
| Long return visit (40+ min) | 103 | $19,087 | $154 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 186 | $15,201 | $55 |
| New patient visit (45+ min) | 100 | $14,040 | $140 |
| New patient visit (60+ min) | 56 | $10,513 | $188 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 117 | $9,564 | $67 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 208 | $8,975 | $32 |
| Short return visit | 145 | $8,869 | $48 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 82 | $5,590 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 224 | $3,432 | $10 |
| New patient visit (30+ min) | 25 | $2,292 | $92 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $1,958 | $85 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $793 | $66 |
| Injection, methylprednisolone acetate, 80 mg | 20 | $193 | None |
2020: 17 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 171 | $27,162 | $111 |
| Return visit (30+ min) | 189 | $26,028 | $85 |
| Short return visit (20+ min) | 168 | $16,219 | $61 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 145 | $12,251 | $51 |
| New patient visit (45+ min) | 96 | $11,996 | $125 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 96 | $8,050 | $63 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 171 | $8,020 | $33 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 64 | $4,613 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 183 | $3,159 | $10 |
| New patient visit (30+ min) | 33 | $2,766 | $84 |
| New patient visit (60+ min) | 15 | $2,628 | $175 |
| Short return visit | 43 | $1,826 | $39 |
| Long return visit (40+ min) | 13 | $1,741 | $124 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,284 | $76 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 14 | $851 | $57 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $831 | $69 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $63 | None |
2019: 16 services
| Return visit (30+ min) | 281 | $45,769 | $88 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 229 | $34,973 | $113 |
| New patient visit (45+ min) | 150 | $19,131 | $128 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 196 | $15,497 | $52 |
| Short return visit (20+ min) | 158 | $10,392 | $55 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 227 | $9,924 | $32 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 122 | $9,315 | $63 |
| New patient visit (60+ min) | 44 | $7,246 | $165 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 83 | $5,528 | $58 |
| Long return visit (40+ min) | 38 | $4,952 | $118 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 256 | $3,575 | $10 |
| New patient visit (30+ min) | 27 | $2,337 | $87 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 30 | $1,767 | $57 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $997 | $77 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $832 | $69 |
| Injection, methylprednisolone acetate, 40 mg | 12 | $60 | None |
2018: 19 services
| Return visit (30+ min) | 316 | $44,333 | $80 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 255 | $39,606 | $112 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 254 | $31,862 | $92 |
| New patient visit (45+ min) | 186 | $22,534 | $121 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 220 | $15,727 | $51 |
| Short return visit (20+ min) | 146 | $10,590 | $58 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 138 | $10,497 | $60 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 85 | $5,540 | $55 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 270 | $3,905 | $10 |
| Mri scan of lower spinal canal without contrast | 22 | $3,843 | $175 |
| New patient visit (60+ min) | 16 | $2,632 | $164 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 201 | $2,331 | $9 |
| New patient visit (30+ min) | 27 | $2,139 | $79 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,746 | $73 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 20 | $1,394 | $66 |
| Long return visit (40+ min) | 11 | $1,340 | $112 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 17 | $1,007 | $59 |
| Short return visit | 26 | $923 | $36 |
| Injection, methylprednisolone acetate, 40 mg | 13 | $69 | None |
2017: 19 services
| Return visit (30+ min) | 304 | $39,316 | $79 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 251 | $38,694 | $116 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 233 | $29,843 | $97 |
| New patient visit (45+ min) | 203 | $25,153 | $124 |
| Mri scan of lower spinal canal without contrast | 136 | $24,899 | $180 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 189 | $14,659 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 140 | $10,419 | $59 |
| Short return visit (20+ min) | 148 | $10,292 | $55 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 100 | $7,290 | $57 |
| Mri scan of upper spinal canal without contrast | 29 | $5,145 | $177 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 273 | $3,694 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 252 | $3,140 | $9 |
| Mri scan of leg joint without contrast | 15 | $3,059 | $191 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 28 | $2,297 | $70 |
| New patient visit (30+ min) | 23 | $1,938 | $84 |
| New patient visit (60+ min) | 11 | $1,852 | $168 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 11 | $1,466 | $92 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 22 | $1,337 | $56 |
| Short return visit | 11 | $433 | $36 |
2016: 19 services
| Return visit (30+ min) | 345 | $46,867 | $81 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 253 | $39,219 | $119 |
| Mri scan of lower spinal canal without contrast | 147 | $26,829 | $179 |
| New patient visit (45+ min) | 209 | $26,267 | $126 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 225 | $26,160 | $97 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 202 | $16,209 | $53 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 164 | $11,858 | $61 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 270 | $11,621 | $32 |
| Short return visit (20+ min) | 145 | $11,101 | $58 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 112 | $7,860 | $58 |
| Mri scan of upper spinal canal without contrast | 26 | $4,778 | $177 |
| Mri scan of arm joint without contrast | 15 | $3,149 | $185 |
| Mri scan of leg joint without contrast | 13 | $2,486 | $191 |
| New patient visit (30+ min) | 31 | $2,440 | $79 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 26 | $2,111 | $75 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 29 | $2,004 | $61 |
| Mri scan of middle spinal canal without contrast | 12 | $1,908 | $159 |
| Short return visit | 16 | $574 | $36 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 13 | $417 | $30 |
2015: 20 services
| Return visit (30+ min) | 337 | $46,789 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 247 | $37,845 | $122 |
| Mri scan of lower spinal canal without contrast | 176 | $31,461 | $173 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 223 | $26,615 | $97 |
| New patient visit (45+ min) | 166 | $21,347 | $129 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 206 | $16,423 | $53 |
| New patient visit (60+ min) | 81 | $12,908 | $159 |
| Short return visit (20+ min) | 167 | $11,927 | $58 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 259 | $10,863 | $32 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 134 | $9,605 | $59 |
| Mri scan of upper spinal canal without contrast | 46 | $7,556 | $164 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 82 | $5,872 | $59 |
| Mri scan of lower spinal canal before and after contrast | 13 | $4,124 | $317 |
| Mri scan of leg joint without contrast | 18 | $3,344 | $176 |
| New patient visit (30+ min) | 33 | $2,620 | $79 |
| Mri scan of middle spinal canal without contrast | 15 | $2,483 | $166 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 25 | $1,592 | $61 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 15 | $1,293 | $76 |
| Short return visit | 16 | $689 | $36 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 14 | $477 | $30 |
2014: 20 services
| Mri scan of lower spinal canal without contrast | 214 | $42,849 | $198 |
| Return visit (30+ min) | 301 | $39,381 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 236 | $34,820 | $119 |
| New patient visit (45+ min) | 172 | $22,099 | $128 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 186 | $20,893 | $99 |
| New patient visit (60+ min) | 108 | $17,739 | $164 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 181 | $13,585 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 165 | $12,984 | $63 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 259 | $10,518 | $32 |
| Short return visit (20+ min) | 141 | $10,116 | $57 |
| Mri scan of upper spinal canal without contrast | 51 | $8,618 | $166 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 117 | $7,777 | $58 |
| Mri scan of lower spinal canal before and after contrast | 16 | $5,298 | $331 |
| Mri scan of leg joint without contrast | 18 | $4,183 | $199 |
| Long return visit (40+ min) | 33 | $3,997 | $114 |
| Mri scan of middle spinal canal without contrast | 18 | $3,539 | $197 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 34 | $2,070 | $61 |
| New patient visit (30+ min) | 21 | $1,742 | $83 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,127 | $47 |
| Ultrasonic guidance for needle placement | 15 | $980 | $61 |
2013: 19 services
| Mri scan of lower spinal canal without contrast | 167 | $53,611 | $315 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 186 | $22,050 | $94 |
| New patient visit (45+ min) | 155 | $20,299 | $131 |
| Short return visit (20+ min) | 219 | $18,561 | $57 |
| Return visit (30+ min) | 177 | $17,948 | $84 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 169 | $15,735 | $42 |
| Mri scan of upper spinal canal without contrast | 49 | $14,867 | $303 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 228 | $9,424 | $32 |
| Mri scan of lower spinal canal before and after contrast | 17 | $8,011 | $471 |
| New patient visit (60+ min) | 47 | $7,648 | $163 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 106 | $5,821 | $47 |
| Mri scan of leg joint without contrast | 15 | $4,445 | $212 |
| New patient visit (30+ min) | 51 | $4,217 | $83 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 79 | $4,215 | $44 |
| Short return visit | 102 | $4,122 | $35 |
| Mri scan of middle spinal canal without contrast | 12 | $4,110 | $316 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 17 | $3,907 | $103 |
| Mri scan of pelvis without contrast | 11 | $3,761 | $342 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 19 | $1,000 | $45 |
Drugs they prescribed that Part D paid
$1,502
Pharmacies billed $1,502 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 47% of their Part D prescriptions (53 of 112) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%.
112 generic and 0 brand-name prescriptions · $1,502 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 45 | $595 | $13 |
| Gabapentin | 16 | $364 | $23 |
| Diazepam | 14 | $14 | $1 |
Year by year
| 2024 | 112 | 58 | 47% (53) | 0% | $1,502 |
| 2023 | 75 | 35 | 53% (40) | 0% | $942 |
| 2022 | 119 | 48 | 21% (25) | None | $4,829 |
| 2021 | 105 | 52 | 23% (24) | None | $5,277 |
| 2020 | 74 | 34 | 20% (15) | None | $5,294 |
| 2019 | 89 | 43 | None | None | $4,958 |
| 2018 | 96 | 53 | 42% (40) | None | $5,724 |
| 2017 | 78 | 45 | 47% (37) | None | $1,887 |
| 2016 | 120 | 62 | 52% (62) | None | $3,470 |
| 2015 | 92 | 58 | 53% (49) | None | $3,128 |
| 2014 | 131 | 69 | 50% (66) | 8% | $9,137 |
| 2013 | 118 | 65 | 54% (64) | None | $3,345 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Hydrocodone-Acetaminophen | 31 | $267 | $9 |
2022: 4 drugs
| Pregabalin | 12 | $699 | $58 |
| Gabapentin | 36 | $434 | $12 |
| Cyclobenzaprine | 13 | $301 | $23 |
| Hydrocodone-Acetaminophen | 22 | $241 | $11 |
2021: 2 drugs
| Gabapentin | 38 | $458 | $12 |
| Hydrocodone-Acetaminophen | 16 | $179 | $11 |
2020: 1 drug
| Gabapentin | 31 | $306 | $10 |
2019: 3 drugs
| Celecoxib | 20 | $394 | $20 |
| Gabapentin | 21 | $161 | $8 |
| Diazepam | 12 | $16 | $1 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 35 | $585 | $17 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 35 | $567 | $16 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 59 | $1,950 | $33 |
| Diazepam | 14 | $20 | $1 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 46 | $1,398 | $30 |
| Diazepam | 17 | $32 | $2 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 61 | $2,131 | $35 |
| Diazepam | 28 | $58 | $2 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 55 | $796 | $14 |
| Diazepam | 25 | $42 | $2 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2021 | 2 | 2 | None | $47 |
| 2020 | 2 | 2 | None | $27 |
| 2019 | 2 | 7 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Wavewriter Alpha Prime 16 | $26 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-02-13 | Wavewriter Alpha Prime 16 | $26 |
See earlier years (2021, 2020, 2019)
2021: $47
| Zimmer Biomet Holdings | Ebi Bone Healing System | $33 | 1 payment
|
| Boston Scientific | Vertiflex Superion | $14 | 1 payment
|
2020: $27
| Assertio Therapeutics | Gralise | $16 | 1 payment
|
| Medtronic USA | Intellis | $11 | 1 payment
|
2019: $93
| Assertio Therapeutics | Gralise | $58 | 4 payments
|
| Collegium Pharmaceutical | Xtampza | $35 | 3 payments
|
Professional record
- NPI
- 1326063389
- Licence
- CA G53496California G53496: Current · expires 2027-12-31
- Trained
- University of California, Geffen School of Medicine, 1983 · 43 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X); Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- 2801 K Street, Ste 500j, Sacramento, CA, 95816
- NPI first listed
- 2006-07-12
- NPI last updated
- 2025-03-14
- NPI record certified
- 2025-03-14
This is when the NPI record was last certified, not a medical board exam.